Money
The Northern Irish pharmacy regulator has confirmed plans to increase annual fees to £477, weeks after the Professional Standards Authority (PSA) “identified weaknesses in multiple [of its] regulatory functions”.
Contractors will reap the benefits of the increased single activity fee (SAF) without having to wait 60 days from the end of April and May, Community Pharmacy England (CPE) has announced.
The DH has revealed plans to expand the pharmacy RSV vaccine programme by “up to 200 sites in identified target areas” in 2025/26 to “reverse the downward trend” in uptake.
Following the announcement of the long-awaited pharmacy funding deal, C+D sets out a timeline of when changes are due to be implemented over the course of the next year…
Along with the long-awaited pharmacy funding deal for 2025/26 came several government commitments on what the sector can expect in the future contract – so what exactly has been pledged?
The GPhC has issued a warning about “emerging issues” taking place in some community pharmacies including the supply of unlicensed ‘Lemon Bottle’ injections – which claim to dissolve fat – and “alternative therapy services” such as acupuncture and cupping.
Last week saw the funding deal finally drop, and while pharmacies were waiting to see if the contract came with a funding allocation for this month’s NICs hike, they were left disappointed. So what does this mean for the sector now?
Paydens has stressed that the multimillion-pound loss reported in its new financial documents does “not accurately depict [its] current financial strength”.
‘Up to’ £8 million is set to be spent on pharmacy “digital developments” over the next year, the Department of Health and Social Care (DH) has announced.
The pharmacy hypertension service specification is set to be updated to exclude patients who request “frequent measurement of their blood pressure”.